Roche Holding AG (RHHBY) Receives $38.00 Average PT from Brokerages
Shares of Roche Holding AG (OTCMKTS:RHHBY) have been given a consensus recommendation of “Hold” by the thirteen analysts that are covering the firm, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating on the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $38.00.
RHHBY has been the topic of a number of research reports. Berenberg Bank downgraded shares of Roche Holding AG from a “buy” rating to a “hold” rating in a research note on Tuesday, October 24th. Cowen and Company reaffirmed a “buy” rating and issued a $38.00 price target on shares of Roche Holding AG in a research note on Tuesday, September 19th. Citigroup Inc. downgraded shares of Roche Holding AG from a “buy” rating to a “neutral” rating in a research note on Wednesday, October 18th. BNP Paribas downgraded shares of Roche Holding AG from a “neutral” rating to an “underperform” rating in a research report on Tuesday, September 26th. Finally, Morgan Stanley reissued an “equal weight” rating on shares of Roche Holding AG in a research report on Wednesday, July 26th.
A number of hedge funds have recently added to or reduced their stakes in the business. Lenox Wealth Management Inc. boosted its holdings in Roche Holding AG by 49.0% during the third quarter. Lenox Wealth Management Inc. now owns 98,282 shares of the company’s stock valued at $3,145,000 after acquiring an additional 32,335 shares during the period. Sterling Capital Management LLC boosted its holdings in Roche Holding AG by 4.6% during the third quarter. Sterling Capital Management LLC now owns 58,107 shares of the company’s stock valued at $1,856,000 after acquiring an additional 2,535 shares during the period. Patten Group Inc. lifted its stake in shares of Roche Holding AG by 12.2% in the third quarter. Patten Group Inc. now owns 29,741 shares of the company’s stock valued at $847,000 after buying an additional 3,239 shares during the period. Finally, Stonebridge Capital Advisors LLC bought a new stake in shares of Roche Holding AG in the third quarter valued at about $221,000. Institutional investors own 0.59% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: “Roche Holding AG (RHHBY) Receives $38.00 Average PT from Brokerages” was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another website, it was illegally copied and reposted in violation of United States and international trademark & copyright laws. The legal version of this report can be read at https://www.thecerbatgem.com/2017/11/23/roche-holding-ag-rhhby-receives-38-00-average-pt-from-brokerages.html.
About Roche Holding AG
Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.
Receive News & Stock Ratings for Roche Holding AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding AG and related stocks with our FREE daily email newsletter.